Kappa opioid receptor agonists inhibit sigma-1 (σ1) receptor binding in guinea-pig brain, liver and spleen: Autoradiographical evidence

Brain Research

Volumn 725, Issue 2, 1996, Pages 155-165

  Brent, Paul J ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Autoradiography; Guinea pig brain; Kappa opioid; Liver; Receptor binding; Sigma binding site; Spleen

Indexed keywords

1 (3 CHLORO 4 CYCLOHEXYLPHENYL) 3 (HEXAHYDRO 1 AZEPINYL)PROPENE; 1,3 BIS(2 METHYLPHENYL)GUANIDINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 3,4 DICHLORO N [1 ISOPROPYL 2 (1 PYRROLIDINYL)ETHYL] N METHYLBENZENEACETAMIDE; BREMAZOCINE; HALOPERIDOL; KAPPA OPIATE RECEPTOR; LIGAND; OPIATE AGONIST; PENTAZOCINE; PRECLAMOL; RIMCAZOLE; SIGMA OPIATE RECEPTOR; SPIRADOLINE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING KINETICS; BRAIN; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GUINEA PIG; LIVER; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

EID: 0030182474     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00170-9     Document Type: Article

References (58)

1. [1] Bowen, W.D., Biochemical pharmacology of sigma receptors, In T.W. Stone (Ed.), Aspects of Synaptic Transmission, Vol II, Taylor and Francis, London, 1993, pp. 113-136.
2. [2] Brent, P.J., Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs, Psychopharmacology, 105 (1991) 421-427.
3. 5 enkephalin and U50,488H differentially affect the locomotor activity and behaviours induced by quinpirole in guinea-pigs, Psychopharmacology, 107 (1992) 581-590.
4. [4] Brent, P.J., Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea-pigs, Neuropharmacology, 32 (1993) 751-760.
5. [5] Brent, P.J., Chahl, L.A., Cantarella, P.A. and Kavanagh, C., The κ-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs, Eur. J. Pharmacol., 241 (1993) 149-156.
6. 3H]spiperone binding to the guinea-pig striatum: autoradiographic evidence, Brain Res., 654 (1994) 191-199.
7. [7] Brent, P.J., Haloperidol and reduced haloperidol-induced exacerbation of the dystonia produced by the κ opioid U50,488H in guinea-pigs is associated with inhibition of σ binding sites: behavioural and autoradiographical studies, Brain Res., (1995) in press.
8. 3H](+)-pentazocine binding sites on cells of the immune system, J. Neuroimmunol., 35 (1991) 153-165.
9. [9] Carr, D.J.J., Mayo, S., Woolley, T.W. and De Costa, B.R., Immunoregulatory properties of (+)pentazocine and sigma ligands, Immunology, 77 (1992) 527-531.
10. [10] Casellas, P., Bourrie, B., Canat, X., Carayon, P., Buisson, I., Paul, R., Breliere, J.C. and Le Fur, G., Immunopharmacological profile of SR 31747: In vitro and in vivo studies on humoral and cellular responses, J. Neuroimmunol., 52 (1994) 193-203.
11. 50) of an enzymatic reaction, Biochem. Pharmacol., 22 (1973) 3099-3105.
12. 1 system, Eur. J. Pharmacol., 250 (1993) R7-R8.
13. [13] Chien, C.C. and Pasternak, G.W., Selective antagonism of opioid analgesia by a sigma system, J. Pharmacol. Exp. Ther., 271 (1994) 1583-1590.
14. [14] Deroq, J-M., Bourrie, B., Segui, M., Le Fur, G. and Casellas, P., In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747, J. Pharmacol. Exp. Ther., 272 (1995) 224-230.
15. [15] Ellis, Y. and Davies, J.A., The effects of sigma ligands on the release of glutamate from rat striatal slices, Naunyn-Schmiedeberg's Arch. Pharmacol., 350 (1994) 143-148.
16. [16] Faden, A.I. and Salzman, S., Pharmacological strategies in CNS trauma, Trends Pharmacol. Sci., 13 (1992) 29-35.
17. [17] Ferris, R.M., Tang, F.L.M., Chang, K.-J. and Russell, A., Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brain, Life Sci., 38 (1986) 2329-2337.
18. [18] Fiorica-Howells, E. and Spector, S., Selectivity of some 'specific' opioid ligands?, Prog. Clin. Biol. Res., 328 (1989) 85-88.
19. [19] Garza, H., Jr., Mayo, S., Bowen, W.D., DeCosta, B.R. and Carr, D.J., Characterization of a (+)-azidophenazocine-sensitive sigma receptor on splenic lymphocytes, J. Immunol., 151 (1993) 4672-4680.
20. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons, Science, 250 (1990) 1429-1432.
21. 3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine, J Neurosci., 6 (1986) 1757-1770.
22. [22] Hall, E.D., Wolf, D.L., Althaus, J.S. and Von Voightlander, P.F., Beneficial effects of the kappa opioid receptor agonist U50,488H in experimental acute brain and spinal cord injury, Brain Res., 435 (1987) 174-180.
23. [23] Itoh, J., Ukai, M. and Kameyama, T., U50,488H, a κ-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice, Brain Res., 619 (1993) 223-228.
24. [24] James, I.F. and Goldstein A., Site-directed alkylation of multiple opioid receptors. I. Binding selectivity, Mol. Pharmacol., 25 (1984) 337-342.
25. 3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea-pig brain membranes, Eur. J. Pharmacol., 193 (1991) 21-27.
26. 3 H]phenyl)guanidine, Proc. Natl. Acad. Sci., USA, 85 (1988) 2844-2848.
27. [27] Leitner, M.L., Hohmann, A.G., Patrick, S.L. and Walker, J.M., Regional variation in the ratio of σ1 to σ2 binding in rat brain, Eur. J. Pharmacol., 259 (1994) 65-69.
28. [28] Liu, Y., Whitlock, B.B., Pultz, J.A. and Wolfe, S.A. Jr., Sigma-1 receptors modulate functional activity of rat splenocytes, J. Neuroimmunol., 59 (1995) 143-154.
29. [29] Lobner, D. and Lipton, P., Sigma-ligands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischaemia, Neurosci. Lett., 117 (1990) 169-174.
30. [30] Luparello, T.J., Stereotaxic Atlas of the Forebrain of the Guinea Pig, Karger, Basel, 1967.
31. [31] Martin, W.R., Pharmacology of opioids, Pharmacol. Rev., 35 (1984) 283-323.
32. [32] McCann, D.J., Weissman, A.D. and Su, T-P., Sigma-1 and sigma-2 sites in rat brain; comparison of regional ontogenetic and subcellular patterns, Synapse, 17 (1994) 182-189.
33. [33] McClean, S. and Weber, E., Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea-pig brain, Neuroscience, 25 (1988) 259-269.
34. [34] Milan, M., κ-opioid receptors and analgesia, Trends Pharmacol. Sci., 11 (1990) 70-76.
35. [35] Nock, B., Giordano, A.L. and Cicero, T.J., ICI 197067 is a selective ligand for the U-69593-sensitive κ opiate binding site, Eur. J. Pharmacol., 162 (1989) 385-386.
36. [36] Paul, R., Lavastre, S., Floutard, D., Floutard, R., Canat, X., Casellas, P., Le fur, G. and Breliere, J.-C., Allosteric modulation of peripheral sigma binding sites by a new selective ligand, SR 31747, J. Neuroimmunol., 52 (1994) 183-192.
37. [37] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
38. [38] Poncelet, M., Santucci, V., Paul, R., Gueudet, C., Lavastre, S., Guitard, J., Steinberg, R., Terranova, J.P., Breliere, J.C., Soubrie, P. and Le Fur, G., Neuropharmacological profile of a novel selective ligand of the sigma site: SR 31742A, Neuropharmacology, 32 (1993) 605-615.
39. [39] Pontecorvo, M.J., Karbon, E.W., Goode, S., Clissold, D.B., Borosky, S.B., Patch, R.J. and Ferkany, J.W., Possible cerebroprotective and in vivo antagonist activities of sigma agents, Brain Res. Bull., 26 (1991) 461-465.
40. [40] Quirion, R., Bowen, W.D., Itzhak, Y., Junien, J.L., Musacchio, J.M., Rothman, R.B., Su, T.-S., Tam, W. and Taylor, D.P., A proposal for the classification of sigma binding sites, Trends Pharmacol. Sci., 13 (1992) 85-86.
41. [41] Ross, S.V., Is the sigma opiate receptor a proadifen-sensitive subform of cytochrome P-450? Pharmacol. Toxicol., 67 (1990) 93-94.
42. [42] Ross, S.V., Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450, Pharmacol. Toxicol., 68 (1991) 293-301.
43. [43] Saini, P., Whitlock, B.B., Liu, Y., Ho, R.H. and Wolfe, S.A. Jr., Binding sites for sigma ligands in rat spleen: differential localization of three distinct sites, Soc. Neurosci., 21 (1995) 631.14.
44. [44] Steiner, H. and Gerfen, C.R., Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum, J. Comp. Neurol., 353 (1995) 200-212.
45. [45] Su, T.P., London, E.D. and Jaffe, J.H., Steroid binding at sigma receptors suggests a link between endocrine, nervous and immune systems, Science (New York), 24 (1988) 219-221.
46. [46] Tam, S.W., Naloxone-inaccessible sigma receptor in rat central nervous system, Proc. Natl. Acad. Sci., USA, 80 (1983) 6703-6707.
47. 3H]ethylketocyclazocine, μ, κ, δ and phencyclidine binding sites in guinea-pig brain membranes, Eur. J. Pharmacol., 109 (1985) 33-41.
48. [48] Tang, A.H., Protection from cerebral ischemia by U50,488H, a specific κ-specific analgesic agent, Life Sci., 37 (1985) 1475-1482.
49. [49] Tortella, F.C., Pellicano, M. and Bowery, N.G., Dextromethorphan and neuromodulation: old drug coughs up new activities, Trends Pharmacol. Sci., 10 (1989) 501-507.
50. [50] Von Voigtlander, P.F., Lahti, R.A. and Ludens, J.H., U50,488H: A selective and structurally novel non-mu (kappa) opioid agonist, J. Pharmacol. Exp. Ther., 234 (1983) 7-12.
51. [51] Von Voigtlander, P.F. and Lewis, R.A., Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid, J. Pharmacol. Exp. Ther., 246 (1988) 259-262.
52. [52] Walker, J.M., Bowen, W.D., Walker, F.O., Matsumoto, R.R., De Costa, B. and Rice, K.C., Sigma receptors: Biology and Function, Pharmacol. Rev., 42 (1990) 355-402.
53. [53] Whitlock, B.B. and Wolfe, S.A. Jr., T lymphocyte production of interleukin 2 (IL-2) is regulated by sigma-1 receptors, Soc. Neurosci., 21 (1995) 631.16.
54. [54] Wolfe, S., Jr., Culp, S.G. and De Souza, E.B., σ-receptors in endocrine organs: Identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary, Endocrinology, 124, (1988) 1160-1172.
55. [55] Wolfe, S., Jr., Kulsakdinun, C., Battaglia, G., Jaffe, J.H. and DeSouza, E.B., Initial identification and characterization of sigma receptors on human peripheral blood leukocytes, J. Pharmacol. Exp. Ther., 247, (1989) 1114-1119.
56. [56] Wolfe, S.A., Jr. and De Souza, E.B., Sigma receptors in the brain-endocrine-immune axis. In J-M., Kamenka and E.F. Domino (Eds.), Mechanisms for Neuromodulation and Neuroprotection?, NPP Books, Ann Arbor, MI, 1992, 927 pp.
57. [57] Young, G.A., Marquis, K.L., Paquette, N.C., Gussio, R.P. and Khazan, N., Haloperidol pretreatment unmasks the kappa opioid effects of U-50,488H on cortical EEG and EEG power spectra in rats, Neuropharmacology, 28 (1989) 881-884.
58. [58] Young, G.A., Hudson, G.M., Stamidis, H. and Steinfels, G.F., Interactions between U50,488H and σ receptor antagonists: EEG, EEG power spectral and behavioural correlates, Eur. J. Pharmacol., 231 (1993) 473-476.